These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 29484273)
1. Home versus hospital immunoglobulin treatment for autoimmune neuropathies: A cost minimization analysis. Le Masson G; Solé G; Desnuelle C; Delmont E; Gauthier-Darnis M; Puget S; Durand-Zaleski I Brain Behav; 2018 Feb; 8(2):e00923. PubMed ID: 29484273 [TBL] [Abstract][Full Text] [Related]
2. Economic costs and quality of life in chronic inflammatory neuropathies in southeast England. Mahdi-Rogers M; McCrone P; Hughes RA Eur J Neurol; 2014; 21(1):34-9. PubMed ID: 23930744 [TBL] [Abstract][Full Text] [Related]
13. Intravenous immunoglobulin for treatment of chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy in France: are daily practices in accordance with guidelines? Rosier C; Graveline N; Lacour A; Antoine JC; Camdessanché JP Eur J Neurol; 2019 Apr; 26(4):575-580. PubMed ID: 30326184 [TBL] [Abstract][Full Text] [Related]
14. Diagnosis and treatment of chronic acquired demyelinating polyneuropathies. Latov N Nat Rev Neurol; 2014 Aug; 10(8):435-46. PubMed ID: 24980070 [TBL] [Abstract][Full Text] [Related]
15. Intravenous immunoglobulins in patients with clinically suspected chronic immune-mediated neuropathy. Lucke IM; Adrichem ME; Wieske L; van der Kooi AJ; Verhamme C; van Schaik IN; Eftimov F J Neurol Sci; 2019 Feb; 397():141-145. PubMed ID: 30623818 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of different brands of intravenous immunoglobulin in the maintenance treatment of chronic immune-mediated neuropathies. Gallia F; Balducci C; Nobile-Orazio E J Peripher Nerv Syst; 2016 Jun; 21(2):82-4. PubMed ID: 26817673 [TBL] [Abstract][Full Text] [Related]
18. Efficacy and patient satisfaction in the use of subcutaneous immunoglobulin immunotherapy for the treatment of auto-immune neuromuscular diseases. Sala TP; Crave JC; Duracinsky M; Lepira Bompeka F; Tadmouri A; Chassany O; Cherin P Autoimmun Rev; 2018 Sep; 17(9):873-881. PubMed ID: 30005853 [TBL] [Abstract][Full Text] [Related]
19. Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviews. Oaklander AL; Lunn MP; Hughes RA; van Schaik IN; Frost C; Chalk CH Cochrane Database Syst Rev; 2017 Jan; 1(1):CD010369. PubMed ID: 28084646 [TBL] [Abstract][Full Text] [Related]
20. Plasma exchange and intravenous immunoglobulins: mechanism of action in immune-mediated neuropathies. Lehmann HC; Hartung HP J Neuroimmunol; 2011 Feb; 231(1-2):61-9. PubMed ID: 21056913 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]